Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Vandormael, Kristel, Riccio, Antonio, Yang, Jing, Pietanza, M Catherine, Brahmer, Julie R
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Gadgeel, Shirish, Rodríguez-Abreu, Delvys, Speranza, Giovanna, Esteban, Emilio, Felip, Enriqueta, Dómine, Manuel, Hui, Rina, Hochmair, Maximilian J, Clingan, Philip, Powell, Steven F, Cheng, Susanna Yee-Shan, Bischoff, Helge G, Peled, Nir, Grossi, Francesco, Jennens, Ross R, Reck, Martin, Garon, Edward B, Novello, Silvia, Rubio-Viqueira, Belén, Boyer, Michael, Kurata, Takayasu, Gray, Jhanelle E, Yang, Jing, Bas, Tuba, Pietanza, M Catherine, Garassino, Marina C
Published in Journal of clinical oncology (10.05.2020)
Published in Journal of clinical oncology (10.05.2020)
Get full text
Journal Article
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
Rudin, Charles M, Awad, Mark M, Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csőszi, Tibor, Cheema, Parneet K, Rodriguez-Abreu, Delvys, Wollner, Mirjana, Yang, James Chih-Hsin, Mazieres, Julien, Orlandi, Francisco J, Luft, Alexander, Gümüş, Mahmut, Kato, Terufumi, Kalemkerian, Gregory P, Luo, Yiwen, Ebiana, Victoria, Pietanza, M Catherine, Kim, Hye Ryun
Published in Journal of clinical oncology (20.07.2020)
Published in Journal of clinical oncology (20.07.2020)
Get full text
Journal Article
Small cell lung cancer: will recent progress lead to improved outcomes?
Pietanza, M Catherine, Byers, Lauren Averett, Minna, John D, Rudin, Charles M
Published in Clinical cancer research (15.05.2015)
Published in Clinical cancer research (15.05.2015)
Get full text
Journal Article
Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline
Rudin, Charles M, Ismaila, Nofisat, Hann, Christine L, Malhotra, Narinder, Movsas, Benjamin, Norris, Kim, Pietanza, M Catherine, Ramalingam, Suresh S, Turrisi, 3rd, Andrew T, Giaccone, Giuseppe
Published in Journal of clinical oncology (01.12.2015)
Published in Journal of clinical oncology (01.12.2015)
Get full text
Journal Article
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Antonia, Scott J, Prof, López-Martin, José A, MD, Bendell, Johanna, MD, Ott, Patrick A, MD, Taylor, Matthew, MD, Eder, Joseph Paul, MD, Jäger, Dirk, MD, Pietanza, M Catherine, MD, Le, Dung T, MD, de Braud, Filippo, Prof, Morse, Michael A, Prof, Ascierto, Paolo A, MD, Horn, Leora, MD, Amin, Asim, MD, Pillai, Rathi N, MD, Evans, Jeffry, Prof, Chau, Ian, MD, Bono, Petri, MD, Atmaca, Akin, MD, Sharma, Padmanee, Prof, Harbison, Christopher T, PhD, Lin, Chen-Sheng, PhD, Christensen, Olaf, MD, Calvo, Emiliano, Dr
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Rudin, Charles M, Prof, Pietanza, M Catherine, MD, Bauer, Todd M, MD, Ready, Neal, Prof, Morgensztern, Daniel, MD, Glisson, Bonnie S, Prof, Byers, Lauren A, MD, Johnson, Melissa L, MD, Burris, Howard A, MD, Robert, Francisco, Prof, Han, Tae H, PhD, Bheddah, Sheila, BA, Theiss, Noah, MS, Watson, Sky, BS, Mathur, Deepan, MD, Vennapusa, Bharathi, MD, Zayed, Hany, PhD, Lally, Satwant, MS, Strickland, Donald K, MD, Govindan, Ramaswamy, Prof, Dylla, Scott J, PhD, Peng, Stanford L, MD, Spigel, David R, MD
Published in The lancet oncology (01.01.2017)
Published in The lancet oncology (01.01.2017)
Get full text
Journal Article
Efficacy and safety of treatments for advanced thymic carcinoma after failure of first-line platinum-based chemotherapy: A systematic literature review and meta-analysis
Arunachalam, Ashwini, Zhang, Ina, Zhao, Bin, Frederickson, Andrew M., Catherine Pietanza, M.
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2023)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2023)
Get full text
Journal Article
Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas
D'ANGELO, Sandra P, CATHERINE PIETANZA, M, JOHNSON, Melissa L, RIELY, Gregory J, MILLER, Vincent A, SIMA, Camelia S, ZAKOWSKI, Maureen F, RUSCH, Valerie W, LADANYI, Marc, KRIS, Mark G
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling
Chaft, Jamie E, Arcila, Maria E, Paik, Paul K, Lau, Christopher, Riely, Gregory J, Pietanza, M Catherine, Zakowski, Maureen F, Rusch, Valerie, Sima, Camelia S, Ladanyi, Marc, Kris, Mark G
Published in Molecular cancer therapeutics (01.02.2012)
Published in Molecular cancer therapeutics (01.02.2012)
Get full text
Journal Article
Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1
Velcheti, Vamsidhar, Hu, Xiaohan, Yang, Lingfeng, Pietanza, M Catherine, Burke, Thomas
Published in Frontiers in oncology (25.03.2022)
Published in Frontiers in oncology (25.03.2022)
Get full text
Journal Article
Reply to F. Liang
Pietanza, M Catherine, Diao, Lixia, Wang, Jing, Byers, Lauren A
Published in Journal of clinical oncology (20.01.2019)
Published in Journal of clinical oncology (20.01.2019)
Get full text
Journal Article
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Naidoo, Jarushka, Murphy, Catherine, Atkins, Michael B, Brahmer, Julie R, Champiat, Stephane, Feltquate, David, Krug, Lee M, Moslehi, Javid, Pietanza, M Catherine, Riemer, Joanne, Robert, Caroline, Sharon, Elad, Suarez-Almazor, Maria E, Suresh, Karthik, Turner, Michelle, Weber, Jeffrey, Cappelli, Laura C
Published in Journal for immunotherapy of cancer (01.03.2023)
Published in Journal for immunotherapy of cancer (01.03.2023)
Get full text
Journal Article
Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non–small cell lung cancer, and renal cell carcinoma
Luke, Jason J., Long, Georgina V., Robert, Caroline, Carlino, Matteo S., Choueiri, Toni K., Haas, Naomi B., O’Brien, Mary, Paz-Ares, Luis, Peters, Solange, Powles, Thomas, Leiby, Melanie A., Lin, Jianxin, Zhao, Yujie, Krepler, Clemens, Perini, Rodolfo F., Catherine Pietanza, M., Samkari, Ayman, Gruber, Todd, Ibrahim, Nageatte, Eggermont, Alexander M.M.
Published in European journal of cancer (1990) (01.08.2024)
Published in European journal of cancer (1990) (01.08.2024)
Get full text
Journal Article
Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to Erlotinib
JANJIGIAN, Yelena Y, AZZOLI, Christopher G, RIELY, Gregory J, KRUG, Lee M, PEREIRA, Leanne K, RIZVI, Naiyer A, CATHERINE PIETANZA, M, KRIS, Mark G, GINSBERG, Michelle S, PAO, William, MILLER, Vincent A
Published in Clinical cancer research (15.04.2011)
Published in Clinical cancer research (15.04.2011)
Get full text
Journal Article
Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker
CATHERINE PIETANZA, M, KADOTA, Kyuichi, CHAN, Timothy A, RIZVI, Naiyer A, AZZOLI, Christopher G, RIELY, Gregory J, KRIS, Mark G, KRUG, Lee M, HUBERMAN, Kety, SIMA, Camelia S, FIORE, John J, SUMNER, Dyana K, TRAVIS, William D, HEGUY, Adriana, GINSBERG, Michelle S, HOLODNY, Andrei I
Published in Clinical cancer research (15.02.2012)
Published in Clinical cancer research (15.02.2012)
Get full text
Journal Article
Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer
Steiniche, Torben, Georgsen, Jeanette Baehr, Meldgaard, Peter, Deitz, Anne C, Ayers, Mark, Pietanza, M Catherine, Zu, Ke
Published in Frontiers in oncology (09.01.2024)
Published in Frontiers in oncology (09.01.2024)
Get full text
Journal Article
Kidney Tubular Toxicity of Maintenance Pemetrexed Therapy
Glezerman, Ilya G., MD, Pietanza, M. Catherine, MD, Miller, Vincent, MD, Seshan, Surya V., MB,BS
Published in American journal of kidney diseases (01.11.2011)
Published in American journal of kidney diseases (01.11.2011)
Get full text
Journal Article
Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation
Wu, Abraham J., Gillis, Andrea, Foster, Amanda, Woo, Kaitlin, Zhang, Zhigang, Gelblum, Daphna Y., Downey, Robert J., Rosenzweig, Kenneth E., Ong, Leonard, Perez, Carmen A., Pietanza, M. Catherine, Krug, Lee, Rudin, Charles M., Rimner, Andreas
Published in Radiotherapy and oncology (01.10.2017)
Published in Radiotherapy and oncology (01.10.2017)
Get full text
Journal Article